Tests Show AAGP® Preserved and Enabled Retinal Cells to Mature Without Compromise after 5-Month Milestone

MARIETTA, Ohio–(BUSINESS WIRE)–#AAGP–ProtoKinetix, Incorporated (www.protokinetix.com) (the “Company” or “ProtoKinetix”) (OTCQB:PKTX) updates shareholders regarding ongoing 3rd stage testing of retinal cell replacement therapy at the University of British Columbia. As previously reported, the Company has demonstrated the ability of AAGP® to protect transplanted cells in a pre-clinical experimental model of retinal degeneration. For the purpose of … [Read more…]

The Health Depot Association Awards Scholarships to Three Members’ Dependents

Funds to be applied to studies in biological science, nursing and design PLANO, Texas–(BUSINESS WIRE)–The Health Depot Association, a national, non-profit organization of entrepreneurs, self-employed professionals and contractors committed to providing access to benefits and resources to its members, has awarded college scholarships to three different recipients. Sonia Chinedu, a sophomore at the University of … [Read more…]

Errant Gene Therapeutics (EGT) Wins Major Victory in New York Court

New York Court Sanctions Bluebird Bio, Paves Way for EGT to Proceed with Massachusetts Lawsuit for Substantial Damages Against Bluebird CEO Nick Leschly and Third Rock Ventures CHICAGO–(BUSINESS WIRE)–Errant Gene Therapeutics (“EGT”) announces that the New York Supreme Court Justice Barry Ostrager sanctioned Bluebird Bio, Inc. (“Bluebird”) and rejected Bluebird’s efforts to prevent EGT from … [Read more…]

Looking for Healthcare Investment Opportunities? Experts at Infiniti Explain Why Now Is the Time to Invest in Central and Eastern Europe

LONDON–(BUSINESS WIRE)–#CompetitiveIntelligence–A well-known market intelligence company, Infiniti Research, has announced the completion of their latest article on exploring healthcare investment opportunities in Central and Eastern Europe. In this article, the experts at Infiniti explore the key factors fueling healthcare investment opportunities in Central and Eastern Europe. Over the past two decades, there has been significant … [Read more…]

Tenax Therapeutics Provides Clinical Development Update

MORRISVILLE, N.C.–(BUSINESS WIRE)–Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, today provided an update on its on-going clinical trial of levosimendan. Clinical Development Update Tenax is conducting a multi-center, double-blind placebo controlled Phase 2 trial designed … [Read more…]

Disarm Therapeutics Announces Science Publications Elucidating Structure and Function of SARM1

SARM1 structure enables drug design for diseases such as multiple sclerosis, amyotrophic lateral sclerosis, and peripheral neuropathies Description of the key role of the NADase pathway in cellular degeneration across species CAMBRIDGE, Mass.–(BUSINESS WIRE)–Disarm Therapeutics, a biotechnology company creating a new class of disease-modifying therapeutics for patients with axonal degeneration, today announced the publication of … [Read more…]

Global Bronchiectasis Drugs Market Outlook 2019-2023 | Availability of Low-Cost Off-Label Generics to Boost Market Growth | Technavio

  LONDON–(BUSINESS WIRE)–#BronchiectasisDrugs–The global bronchiectasis drugs market size is poised to grow by USD 117.57 million during 2019-2023, according to a new report by Technavio, progressing at a CAGR of close to 5% during the forecast period. Read the 131-page research report with TOC on “Bronchiectasis drugs Market Analysis Report by product (antibiotics, expectorants, and … [Read more…]

Global Glioblastoma Multiforme Treatment Market Estimated to grow With a CAGR of 11% During the Forecast Period, 2019-2024 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Glioblastoma Multiforme Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024” report has been added to ResearchAndMarkets.com’s offering. The global glioblastoma multiforme treatment market is expected to grow at a CAGR of around 11% during 2019-2024. Glioblastoma multiforme, also known as grade IV astrocytoma, is a malignant grade IV brain … [Read more…]

Tmunity Announces Participation at Upcoming Investor Conferences

PHILADELPHIA–(BUSINESS WIRE)–Tmunity Therapeutics, Inc., a private clinical-stage biotherapeutics company focused on saving and improving lives by delivering the full potential of next-generation T cell immunotherapy, today announced that Usman “Oz” Azam, MD, President and Chief Executive Officer, and members of the management team plan to participate at two investor conferences in September and October 2019. … [Read more…]

Antimicrobial Susceptibility Testing Market Outlook 2019 – 2023: Government Initiatives to Boost Growth | Technavio

LONDON–(BUSINESS WIRE)–#HealthCare–The global antimicrobial susceptibility testing market size is poised to reach USD 832.14 million by 2023, according to a new report by Technavio, progressing at a CAGR of 5% during the forecast period. Read the 124-page research report with TOC on “Antimicrobial Susceptibility Testing Market Analysis Report by application (clinical diagnostics, drug discovery and … [Read more…]